Wheel Alternatives for Telehealth Brands

What problem should a Wheel alternative solve?

A Wheel alternatives search can begin from very different organizations: a consumer brand, an existing care business, a retailer or a company adding a clinical service to another product. Those buyers do not necessarily need the same patient experience, reporting or commercial workflow. Start with the channel and the service you intend to deliver.

Wheel’s public platform description includes a clinical network, patient experience, EMR and care programs. It is broader than staffing alone. Use the TEHR versus Wheel comparison if you want a detailed comparison of those documented capabilities.

For the wider shortlist, separate a supplied care operation from software used by your own care team. Both can be sensible purchases, but an entry-level software price does not include an independently staffed nationwide service unless a proposal explicitly says so. A fair evaluation compares the complete arrangement required to deliver the intended patient journey.

Which operating models belong on the shortlist?

This shortlist groups different operating models. The order is editorial, with TEHR first, and does not represent independent testing or numerical scores. Vendor statements are presented as of October 22, 2026; a missing public detail means it needs confirmation, not that the capability is absent.

When is TEHR the right alternative to evaluate?

TEHR combines white-label technology and administrative infrastructure with an independent licensed clinical network reaching all 50 states, subject to program, state and patient eligibility. It supports clinician e-prescribing, pharmacy coordination, AI-assisted intake, payments and subscriptions. Clinical decisions remain with independent licensed providers. Its commercial model is a flat platform subscription plus flat transaction fee and 0% revenue share; contact TEHR for a scoped quote. See the platform and pricing scope.

TEHR is worth evaluating when the commercial objective is an own-brand telehealth business with recurring customer relationships and operational support. Ask the team to demonstrate the storefront-to-care handoff and the recurring journey, then identify the work included in the proposal. If your requirement is a specialized enterprise distribution arrangement, confirm that exact scope rather than assuming every branded platform serves every channel equally.

Trade-off: Confirm the actual clinical, pharmacy, support and integration scope before treating a platform proposal as an all-inclusive service. Patients see the brand, while required notices still identify the real care entities. Selected peptide programs are pending and are not open for prescribing or fulfillment.

When should you consider SteadyMD?

Strength: SteadyMD describes a 50-state clinical workforce and clinical operations. Its API materials distinguish limited integration, where clinical work happens in the partner’s EMR, from complete integration using SteadyMD’s EMR. Patient records, intake and diagnostic information can be included in the workflow. Official digital health companies; Telehealth APIs.

Consider SteadyMD when clinical workforce and operational capacity are the primary gaps, particularly if your patient experience or EMR already works. The integration route determines where clinical work happens. Compare that route with the proposed Wheel configuration before treating the vendors as equivalent full-platform replacements.

Trade-off: Do not mistake clinical staffing and integration for a confirmed turnkey commerce package. Request the proposed pharmacy, payment, subscription and administrative scope, plus actual pricing. The reviewed sources do not establish a standard bulk-migration service or deadline.

When should you consider OpenLoop?

Strength: OpenLoop’s Launchpad describes a no-code website, branded portal, intake, clinicians and operating workflows. The current product is broader than a clinician network; its official page also describes integration into existing customer systems. Official launchpad and platform.

Consider OpenLoop when you want a full connected operation under a consumer-facing brand. Its current Launchpad materials describe substantially more than network access. Ask how the platform supports your acquisition channel, patient communications and follow-up, then compare a complete operating package rather than just the stated clinician coverage.

Trade-off: The reviewed page does not establish a universal numeric rate card or revenue-share policy. Request itemized terms and identify the work your team retains. Treat its fastest launch statement as a vendor estimate with readiness conditions, not a migration guarantee.

When should you consider Beluga Health?

Strength: Beluga offers direct API, hosted intake and platform-partner configurations. Its pricing page explicitly describes no cut of customer revenue, flat monthly access, per-visit fees and pharmacy/lab pass-through with disclosed service charges. Dollar amounts are quoted during scoping. Official platform integration paths; Pricing.

Consider Beluga when you want a modular clinical backend and have a clear plan for commerce and patient support around it. Retaining pharmacy or payment relationships may be relevant to an established business. Make the multi-company handoffs explicit so flexibility does not become ambiguity when a patient needs help.

Trade-off: Determine which company supplies commerce, subscriptions and patient support in your chosen configuration. A clinical backend can be the right fit for an existing stack, but its fee alone should not be compared with the price of a complete commercial operation.

When should you consider CareValidate?

Strength: CareValidate describes integrated white-label infrastructure and a nationwide provider network. Its laboratory page outlines both at-home kits and in-person orders, with results connected to charts and provider workflows. Its launch materials describe managed patient support and existing-stack API connectivity. Official provider network; Labs and diagnostics.

Consider CareValidate when diagnostic testing and coordinated fulfillment are important parts of the intended journey. Its lab documentation gives concrete workflows to examine. Ask who manages patient instructions, results visibility and administrative follow-up, and distinguish those tasks from the clinical responsibility for interpreting and acting on findings.

Trade-off: Request an itemized fee schedule and migration scope; neither was established on the reviewed public pages. Confirm which support tasks and lab costs are included. A broadly integrated offering still needs a clear handoff when a patient needs clinical rather than administrative help. Launch telehealth.

When should you consider MD Integrations?

Strength: MD Integrations describes a physician-only network and both API and ready-made patient workflows. Its FAQ covers pharmacy fulfillment and tailored pricing, and explicitly states that it does not prescribe controlled substances. That limitation matters when evaluating a proposed hormone program. Official platform and physician network; FAQ.

Consider MD Integrations when its physician-only approach and stated program boundaries fit the use case. The controlled-substance exclusion is especially relevant if your shortlist includes testosterone services. Confirm that suitability before comparing integration speed, because a fast connection cannot remedy a mismatch in the clinical offering.

Trade-off: Do not infer testosterone prescribing from a broad hormone or men’s-health category. Confirm program eligibility and the exact commercial scope before integrating. The reviewed sources do not establish a standard patient-migration service or a universal numerical rate card.

When should you consider Telegra?

Strength: Telegra describes intake, commerce, pharmacy routing, a branded portal/app and APIs. Its public migration documentation covers CSV imports for patients, products, coupons, orders and subscriptions, with dry-run validation before production import. This is documented import capability, not proof of every outbound export option. Official platform overview; CSV migration.

Consider Telegra when the desired replacement is strongly centered on consumer commerce and a consistent portal or app experience. Review plan-specific features and the ongoing operating charges. If you already have a mature experience, decide whether the benefits of replacing it justify migration, training and communication work.

Trade-off: Request recurring costs separately from published onboarding fees and confirm plan-specific app and pharmacy options. Its conditions page marks peptides Coming Soon; that is not a currently available prescribing or fulfillment program. Conditions and program status.

When should you consider Healthie?

Strength: Healthie offers practice software; full web white-label is an Enterprise add-on. Its documentation describes patient import, with scope varying by plan. Entry-level software prices are not the price of an Enterprise white-label configuration or a supplied nationwide clinical workforce. Official full web white-label; Client data import.

Consider Healthie as an adjacent software option when you already operate the clinical service and primarily need practice tools or a branded patient experience. It should not be treated as a staffed equivalent to Wheel based on software pricing. The clinical workforce and fulfillment arrangements must be supplied and priced separately.

Trade-off: Evaluate it as software for your clinical operation unless a separate proposal establishes more. Identify who supplies clinicians, pharmacy fulfillment and support before comparing the invoice with an integrated telehealth service. A demographic import is not equivalent to a complete clinical migration.

How should you narrow the shortlist?

Write a channel-specific acceptance test. A consumer subscription brand may prioritize repeat orders, payment changes and customer support. An existing clinical business may prioritize chart workflows and staff access. A service embedded inside another product may prioritize identity handoff and integration. The same generic demo cannot settle all three needs.

Request a proposal that identifies the medical practice, clinical roles, program eligibility, patient-facing technology and operational support. Then show the proposed arrangement to the people who will handle patient questions. They should be able to explain where a delayed result, missed message or payment problem goes without guessing.

Use TEHR pricing to understand one commercial model and request equivalent scope from finalists. Do not infer revenue-share terms from missing public pricing. Compare the cost of the relevant patient journey, including retained software and staff, rather than a vendor’s shortest headline.

How should existing patients move to the chosen platform?

A platform change can range from a new clinical connection to a complete patient experience replacement. Decide the scope first. If the current records remain in place, confirm access, routing and clinical responsibility. If records move, validate chart content and identity matching alongside commercial data.

The patient migration checklist helps define these acceptance cases. Ask each vendor for its actual migration process; an integration page does not establish a standard import service or guaranteed deadline. Reconcile active care, upcoming visits and recurring charges before exposing the new experience to the entire population.

What should the final proposal make explicit?

Ask for the service boundaries, itemized charges, implementation dependencies and operational acceptance criteria in writing. Review the white-label telehealth guide if the proposals use the same label for different scopes, and use the resource library to prepare program and migration questions. A good shortlist should become a small set of comparable proposals. It should not end as a ranking that hides unanswered questions about who supplies care, who performs administrative work and what the brand will actually pay.

For a wider category view, compare the white-label telehealth platform shortlist and the turnkey telehealth platform shortlist. Use the first to examine brand and architecture choices, and the second to assess which implementation and operating tasks a proposed package actually supplies.

What else should you know?